Division of Treatment and Recovery Research
National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH
Dr. Bechtholt earned her Ph.D. in Behavioral Neuroscience at Oregon Health & Science University in 2004. Her thesis work examined the role opioid receptors in the conditioned rewarding and aversive properties of ethanol and was supported by an individual predoctoral NRSA from the NIAAA. Dr. Bechtholt’s postdoctoral training in the Department of Psychiatry at the University of Pennsylvania focused on understanding how antidepressants are effective, when they are effective, using a variety of behavioral, neurochemical, pharmacological, and genetic methods. This work was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression. Her independent research program in the Department of Psychiatry at Harvard Medical School – McLean Hospital was focused on understanding the role of glial cells in the treatments and causes of psychiatric disorders including anxiety, depression, schizophrenia and alcoholism. This work was funded by the National Institute for Alcohol Abuse and Alcoholism, the National Institute of Mental Health, a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression, an ABMRF from The Foundation for Alcohol Research, an Eleanor and Miles Shore Harvard Medical School Fellowship, and funds from the Shervert Frazier Research Institute.
Dr. Anita Bechtholt joined the NIAAA Division of Neuroscience and Behavior as a Program Director in November 2012 and transitioned to the Division of Treatment and Recovery Research in 2014. Dr. Bechtholt administers grants related to translation, neuroscience, biomarkers, technology, centers and training.